Day: February 25, 2026
Quakertown, PA and Limerick, PA, Feb. 25, 2026 (GLOBE NEWSWIRE) — QNB Corp. (“QNB” or the “Company”) (OTCQX: QNBC), the holding company for QNB Bank, and The Victory Bancorp, Inc. (“Victory”) (OTCQX: VTYB), the holding company for The Victory Bank, today jointly announced that they have received all required regulatory approvals to complete their previously announced merger transaction (the “Merger”). The transaction, initially announced on September 23, 2025, is expected to close during the second quarter, subject to the satisfaction of customary closing conditions.
About QNB Corp.
QNB Corp. is the holding company for QNB Bank, which is headquartered in Quakertown, Pennsylvania. QNB Bank currently operates twelve branches in Bucks, Lehigh, and Montgomery Counties and offers commercial and retail...
Toll Brothers Announces Final Opportunity to Own a Luxury Home at Woodcrest Hills in Simpsonville, South Carolina
Written by Customer Service on . Posted in Public Companies.
Limited homes remain available in this sought-after Five Forks community
SIMPSONVILLE, S.C., Feb. 25, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity for home shoppers to purchase a new luxury home at Woodcrest Hills, a boutique community located in Simpsonville, South Carolina. Only four new homes remain available for sale in this serene Five Forks enclave.Woodcrest Hills is offering the final selection of quick move-in homes priced from the low $400,000s with move-in dates as early as April 2026. Nestled in an idyllic and natural setting, the community features wooded home sites, open floor plans, and well-appointed kitchens designed to fit every lifestyle.“Woodcrest Hills offers home shoppers a unique combination of sophisticated...
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
Written by Customer Service on . Posted in Public Companies.
DESMODA is the first and only FDA-approved desmopressin oral solution
Commercial launch expected on March 9th
DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of all ages
The product is expected to be a significant long-term growth contributor, with potential peak sales of $30-50 million annually and patent protection extending through 2044DEER PARK, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S. Food and Drug Administration (FDA) approval of a New Drug Application (NDA) for DESMODA™ (desmopressin acetate) Oral Solution for the management of central diabetes insipidus, also...
T3 Defense Inc. Announces Private Placement of up to $20 Million to Accelerate Acquisition Strategy
Written by Customer Service on . Posted in Public Companies.
Two-tranche financing strengthens balance sheet and supports disciplined expansion across defense industrial base
NEW YORK and TEL AVIV, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., today announced that it has entered into definitive agreements for a committed private investment for up to $20 million from Esousa Group Holdings, LLC, a New York-based family office and an existing shareholder. The financing is intended to accelerate the company’s disciplined roll-up strategy, consolidating and scaling high-value suppliers operating at structurally constrained points within the defense industrial base.
The financing is structured in two tranches, with $10 million funded at closing and a second $10 million tranche committed, subject to an effective registration statement covering...
Publication of Annual Report 2025 on 27 February 2026
Written by Customer Service on . Posted in Public Companies.
Publication of Annual Report 2025 on 27 February 2026AttachmentNo. 1 – Publication of Annual Report 2025 on 27 February 2026
Danone: Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report
Written by Customer Service on . Posted in Public Companies.
Press Release – Paris, February 25, 2026, at 7pm CET
Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report
Danone announces that its consolidated financial statements and the statutory auditors’ report for the fiscal year ended December 31, 2025 are publicly available and accessible online on its website, www.danone.com, section Investors / Financial and extra-financial reports.
About Danone (www.danone.com)
Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices...
AMG Critical Materials N.V. Announces Strategic Acquisition of AURA Technologie to Establish First Circular High-Purity Molybdenum Platform
Written by Customer Service on . Posted in Mergers And Acquisitions.
Amsterdam, 25 February 2026 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) acquired AURA Technologie GmbH in Germany for €10 million in a transaction consisting of 34% cash and 66% AMG shares. The acquisition represents a major strategic step in AMG’s expansion into high-purity molybdenum and strengthens its position in circular critical materials processing.
AURA is an established processor of spent hydrodesulfurization (HDS) catalysts, which contain molybdenum as a key active component. The transaction provides AMG with an operational platform and experienced team, accelerating the commercialization of AMG’s proprietary molybdenum refining technology.
“This acquisition marks the launch of AMG’s circular high-purity molybdenum business,” said Michael Connor, AMG’s Chief Corporate Development Officer. “We plan to...
Ilkka Oyj: Acquisition of own shares on 25 February 2026
Written by Customer Service on . Posted in Public Companies.
Ilkka Oyj, Stock Exchange Release, 25 February 2026 at 07:00 p.m. EET
Ilkka Oyj: Acquisition of own shares on 25 February 2026Date
25 February 2026
Exchange transaction
Buy
Share trading code
ILKKA2 FH
Amount, shares
1,547
Average price/share (EUR)
4.2548
Total cost (EUR)
6,582.18
After the acquisitions Ilkka Oyj holds a total of 91,855 treasury shares.
On behalf of Ilkka Oyj
Danske Bank A/S, Finland Branch
Antti Väliaho Jonathan Nyberg
For more information, please contact:Seija Peitso, CFO, Ilkka Oyjseija.peitso@ilkka.com
Ilkka Oyj company descriptionAttachmentILKKA2.HE_20260225
WORLDLINE : FY2025 results : Press release
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
FY2025 in line with guidance
Operational turnaround and transformation on track
FY 2025 results, including MeTS:€4.5B Group revenue1, -2.4% organically vs 2024 (guidance of low single digit percentage decline)
€841M adjusted EBITDA1, 18.7% adj EBITDA margin (guidance at €830m to €855m)
€(9)M free cash flow12 (guidance at €-30M to €0M+) with €(49)M in H2 2025
Net result at €(5,157)M Group Share including €(4,647)M impairments of goodwill
Normalised net results at €175MExcluding MeTS (under IFRS53) revenues, adjusted EBITDA and free cash flow respectively amount to €4.0B, €737M and €(26)M
Turnaround and transformation on trackImproved churn in all geographies and improved order intake and pipeline in financial services in Q4 2025
Transformation initiatives operationalized with benefits in Q4 2025 and clear milestones for 2026
Pruning...
AMG Reports a Solid Set of Full Year 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Amsterdam, 25 February 2026 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports full year adjusted EBITDA of $235 million in 2025, a 40% increase compared to the 2024 adjusted EBITDA of $168 million, driven primarily by our Antimony and Engineering businesses. We ended the year with a strong balance sheet highlighted by our $484 million of total liquidity as of December 31, 2025.
Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “In 2025, we achieved the third highest adjusted EBITDA in the Company’s history despite weakness in lithium and vanadium. This flexible response to a changing market environment highlights the quality and the breadth of our critical materials and technologies portfolio. Governments are pushing for onshoring of critical materials supply,...
